Learning more about how your genes tell your future health
Through its unique and award-winning products, CURE Media Group has become the source of information and inspiration for those on the cancer journey. CURE Media Group's flagship product, CURE magazine, is the indispensable guide for every stage of the cancer experience. Through the magazine, educational forums, a resource guide for the newly diagnosed, a national nursing award, books, and a variety of online tools, CURE Media Group combines science and humanity to make cancer understandable.
My daughter Kirtley was only 13 months old when I was diagnosed with breast cancer in 1986 at age 37. By fall 1991 I was healing emotionally, and Kirtley was a happy, healthy 6-year-old who had inherited my stubborn nature and love of books. Even after the first of the BRCA genes was discovered in 1990, I knew my risk was low. I was the first in my family to get cancer. It was stroke or cardiac issues that removed my family tree limbs. Then my mother was diagnosed with stage 4 breast cancer in the fall of 1991; she died six months later. It was a difficult time for me and became even more difficult as I began to worry about whether I now needed to worry about passing on more than a love of books to my daughter. As I celebrated survivorship and Kirtley grew, I constantly scanned information about genetic testing for breast cancer, feeling sure that we would know more before I should worry.
ACOR▶ a large collection of cancer-related online email lists, which has delivered millions of email messages to subscribers across the globe. https://goo.gl/mjrQ77
An INTRANET is a private network accessible only to an organization's staff or members. Generally a wide range of information and services from the organization's internal IT systems are available that would not be available to the public from the Internet. By function, ACORis an INTRANETsite.
When a #Canswerist (aka cancer survivor or caregiver) looks to begin or extend research for their diagnosis (DX), the world wide web (or internet) is a logical starting points. Typically, such a search may lead to discovery on a range of INTRANETS.
Bone marrow transplants, aka stem cell transplants (SCT) offer a second chance for people with life-threatening blood cancers and other hematologic malignancies. I know because I am one of the SCT success stories from the place known as City of Hope (COH).▶ COH performed its first bone marrow transplant in 1976. Since then, thousands of patients from virtually every state and dozens of countries have undergone bone marrow, cord blood or stem cell transplants at COH.▶ Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood.▶ It may be autologous (the patient's own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from an identical twin).▶ It is a medical procedure in the field of hematology, most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma, lymphoma (my DX) or …
▶ Gradually, but surely, we are now archiving MyJournal posts in our G+ collection. Follow us there.
▶ First day of the winter solstice arrived yesterday and that generally means no real change in the weather conditions for Southern California, but we have finally had a few days of partly-cloudy rain to initiate the official changing of the seasons▶ Unfortunately and personally, the last few months have been mostly marked with prolonged and unrelenting respiratory distress, officially diagnosed last Friday as acute bronchitis.
▶ A new cocktail of medicines have been prescribed: 1) Ibratropium Bromide nasal spray; 2) Prednisone, a steroid; and 3) Benzonatate, a cough suppressant. All of this followed my third IVIG in three months since September at City of Hope, as that last procedure generally lasts me for six months, but not at this time. Immune system issues remain and underlying challenge in my ninth year post DX with mantle cell lymphoma and eight years post the allogeneic stem ce…